Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes.
Mehta MS, Dolfi SC, Bronfenbrener R, Bilal E, Chen C, Moore D, Lin Y, Rahim H, Aisner S, Kersellius RD, Teh J, Chen S, Toppmeyer DL, Medina DJ, Ganesan S, Vazquez A, Hirshfield KM. Mehta MS, et al. Among authors: toppmeyer dl. PLoS One. 2013 Jul 26;8(7):e69851. doi: 10.1371/journal.pone.0069851. Print 2013. PLoS One. 2013. PMID: 23922822 Free PMC article.
Inference of Germline Mutational Status and Evaluation of Loss of Heterozygosity in High-Depth, Tumor-Only Sequencing Data.
Khiabanian H, Hirshfield KM, Goldfinger M, Bird S, Stein M, Aisner J, Toppmeyer D, Wong S, Chan N, Dhar K, Gheeya J, Vig H, Hadigol M, Pavlick D, Ansari S, Ali S, Xia B, Rodriguez-Rodriguez L, Ganesan S. Khiabanian H, et al. Among authors: toppmeyer d. JCO Precis Oncol. 2018;2018:PO.17.00148. doi: 10.1200/PO.17.00148. Epub 2018 Jan 19. JCO Precis Oncol. 2018. PMID: 30246169 Free PMC article.
Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer.
Gorshein E, Matsuda K, Riedlinger G, Sokol L, Rodriguez-Rodriguez L, Eladoumikdachi F, Grandhi M, Ganesan S, Toppmeyer DL, Potdevin L, Toomey K, Hirshfield KM, Chan N. Gorshein E, et al. Case Rep Oncol. 2021 Jun 18;14(2):931-937. doi: 10.1159/000515510. eCollection 2021 May-Aug. Case Rep Oncol. 2021. PMID: 34248561 Free PMC article.
Clinical efficacy of PARP inhibitors in breast cancer.
Pandya K, Scher A, Omene C, Ganesan S, Kumar S, Ohri N, Potdevin L, Haffty B, Toppmeyer DL, George MA. Pandya K, et al. Among authors: toppmeyer dl. Breast Cancer Res Treat. 2023 Jul;200(1):15-22. doi: 10.1007/s10549-023-06940-0. Epub 2023 May 2. Breast Cancer Res Treat. 2023. PMID: 37129747 Review.
94 results